KalVista Pharmaceuticals, Inc.KALVNASDAQ
Loading
Debt to Assets Over TimeCompressed
Percentile Rank42
3Y CAGR-14.4%
5Y CAGR+7.2%
Year-over-Year Change
Debt-to-assets ratio
3Y CAGR
-14.4%/yr
vs +72.4%/yr prior
5Y CAGR
+7.2%/yr
Recent deceleration
Acceleration
-86.9pp
Decelerating
Percentile
P42
Within normal range
vs 5Y Ago
1.4x
Solid growth
Streak
2 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.03 | -19.1% |
| 2024 | 0.03 | -30.8% |
| 2023 | 0.04 | +11.9% |
| 2022 | 0.04 | +84.9% |
| 2021 | 0.02 | +22.2% |
| 2020 | 0.02 | +3789.2% |
| 2019 | 0.00 | -89.9% |
| 2018 | 0.00 | - |
| 2017 | 0.00 | -100.0% |
| 2016 | 0.19 | - |